Sanara MedTech Inc. (SMTI) Financial Analysis & Valuation | Quarter Chart
Sanara MedTech Inc. (SMTI)
SMTIPrice: $20.54
Fair Value: 🔒
🔒score
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote ... more
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, h... more
Description
Shares
| Market Cap | $182.84M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Ronald T. Nixon |
| IPO Date | 1994-04-07 | CAGR | 0.16% |
| Employees | 141 | Website | sanaramedtech.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
SMTI chart loading...
Fundamentals
Technicals
| Enterprise Value | $306.81M | P/E Ratio | -23.89 |
| Forward P/E | 37.24 | PEG Ratio | — |
| P/S Ratio | 1.79 | P/B Ratio | 28.88 |
| P/CF Ratio | 47.06 | P/FCF Ratio | -211.25 |
| EPS | $-1.16 | EPS Growth 1Y | -26.1% |
| EPS Growth 3Y | -50.34% | EPS Growth 5Y | -17.98% |
| Revenue Growth 1Y | 30.55% | Gross Margin | 0.92% |
| Operating Margin | 0% | Profit Margin | -0.37% |
| ROE | -1.27% | ROA | -0.94% |
| ROCE | 0.02% | Current Ratio | 1.8 |
| Quick Ratio | 1.6 | Cash Ratio | 0.86 |
| Debt/Equity | 7.71 | Interest Coverage | 0.07 |
| Altman Z Score | 0.15 | Piotroski Score | 4 |